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Focal Hepatic Lesions: Evaluation with
Contrast-Enhanced Gray-Scale
Harmonic US
Objective: To determine the findings of various focal hepatic lesions at con-
trast-enhanced gray-scale ultrasound (US) using a coded harmonic angio (CHA)
technique and emphasizing lesion characterization.
Materials and Methods: The study involved 95 patients with 105 focal hepatic
lesions, namely 51 hepatocellular carcinomas (HCCs), 22 metastases, 22
hemangiomas, four cases of focal nodular hyperplasia (FNH), and six nontumor-
ous nodules. After the injection of a microbubble contrast agent (SH U 508A),
gray-scale harmonic US studies using a CHA technique were performed with a
combination of continuous scanning to assess the intratumoral vasculature (vas-
cular imaging) and interval-delay scanning to determine the sequential enhance-
ment pattern (acoustic emission imaging). Each imaging pattern was categorized
and analyzed.
Results: At vascular imaging, 69% of HCCs (35/51) showed irregular branch-
ing vessels, while in 91% of metastases (20/22) a peripherally stippled pattern
was observed. Intratumoral vessels were absent in 95% of hemangiomas (21/22)
and all nontumorous lesions (6/6), while in 75% of FNHs (3/4) a spoke-wheel pat-
tern was evident. At acoustic emission imaging, 71% of HCCs (36/51) showed
heterogeneous enhancement and 86% (19/22) of metastases showed rim- or
flame-like peripheral enhancement during the early phase, with washout occur-
ring in all HCCs and metastases (100%, 73/73) during the late phase. In heman-
giomas, enhancement was either peripheral and nodular (19/22, 86%) or persis-
tent and homogeneous (3/22, 14%), and 75% of FNHs (3/4) became isoechoic
during the late phase.
Conclusion: At contrast-enhanced gray-scale US using a CHA technique, a
period of continuous scanning depicted the intratumoral vasculature, and interval-
delay scanning demonstrated the sequential enhancement pattern. The charac-
teristic findings of various focal hepatic lesions were thus determined.
he sensitive detection and characterization of tumor vascularity is crucial
for the differential diagnosis of focal hepatic lesions, and there is increas-
ing consensus that the addition of contrast agents has significantly ex-
panded the current role of ultrasonography (US) into diagnostic territories where CT
and MRI were previously dominant. Although the findings of recent reports are pre-
liminary and further studies with a large patient population are needed to clarify the
definite role of contrast-enhanced US, current results suggest that the modality has
great potential for the detection and characterization of hepatic tumors. However, es-
tablished techniques suffer certain limitations: Doppler studies in which microbubble
agents are used are seriously affected by ‘blooming’ and motion artifacts, and are in-
sensitive to very slow flow (1 4). More recently, various gray-scale harmonic US
Hyun-Jung Jang, MD
1, 2
Hyo K. Lim, MD
1
Won Jae Lee, MD
1
Seong Hyun Kim, MD
1
Min Ju Kim, MD
1
Dongil Choi, MD
1
Soon Jin Lee, MD
1
Jae Hoon Lim, MD
1
Index terms:
Liver neoplasms, US
Ultrasound (US), contrast media
Ultrasound, harmonic study
Ultrasound, technology
Korean J Radiol 2003;4:91-100
Received October 19, 2002; accepted
after revision February 9, 2003.
1Department of Radiology and Center for
Imaging Science, Samsung Medical
Center, Sungkyunkwan University School
of Medicine, Seoul Korea; 
2Department of
Radiology and Center for Liver Cancer,
National Cancer Center, Seoul Korea.
Address reprint requests to:
Hyo Keun Lim, MD, Department of
Radiology, Samsung Medical Center,
Sungkyunkwan University School of
Medicine, 50 Ilwon-dong, Kangnam-gu,
Seoul 135-710, Korea.
Telephone: (822) 3410-2505
Fax: (822) 3410-2559
e-mail: hklim@smc.samsung.co.kr
Ttechniques have been reported to be useful in characteriz-
ing hepatic tumors (5 8). For visualization of sufficient
stimulated acoustic emission (SAE) effect, these, however,
usually require maximal mechanical index (MI), and strict
intermittent scanning is thus necessary (9, 10). This causes
technical difficulties, however, and generally provides less
helpful information from vascular imaging, especially with
a fragile air-based contrast agent such as SH U 508A.
Coded harmonic angio (CHA) is a new US technique
that is specifically sensitive to signals from a contrast agent
but does not give rise to contrast-related artifacts. Its ex-
treme sensitivity to contrast agents provides sufficient SAE
effect at medium MI and, at the same time, since there is
less destruction of microbubbles, a period of continuous
scanning is possible with excellent depiction of intratu-
moral microvasculature. We found that CHA in conjunc-
tion with a scan technique exploiting both vascular and
acoustic emission imaging accurately represented the vas-
cular characteristics of various focal hepatic lesions.
The purpose of this study was to describe the contrast-
enhancement patterns of various focal hepatic lesions at
CHA, emphasizing lesion characterization.
MATERIALS AND METHODS
Subjects
During a recent six-month period, 104 consecutive pa-
tients with 114 focal hepatic lesions and no history of treat-
ment were examined using a CHA technique in conjunc-
tion with a microbubble contrast agent. Nine lesions in
nine patients were excluded: five lesions were not properly
scanned according to our protocol, and in four cases the di-
agnosis was not verified. Finally, 95 patients with 105 focal
hepatic lesions were included: 51 patients with 51 hepato-
cellular carcinomas (HCCs), 16 with 22 hepatic metastases,
18 with 22 hemangiomas, four with focal nodular hyper-
plasia (FNH), three with focal eosinophilic necrosis (FEN),
two with inflammatory nodules, and one with focal fatty
lesion. Lesions ranged in size from 0.7 to 6.9 (mean, 2.6)
cm, and at the time of patient recruitment the diagnosis
was unknown. In four patients with metastases and four
with hemangiomas, two or three lesions were included in
one scanning plane. In each of the remaining patients, one
lesion was scanned. Patients with HCCs were 30 74
(mean, 56.3) years old, those with metastases were 34 77
(mean, 60.5), those with hemangiomas were 28 75
(mean, 52.7), those with FNH were 33 62 (mean, 46.5),
and the remaining patients with nontumorous lesions were
36 65 (mean, 51.2). Men accounted for 41 of the 51 pa-
tients with HCCs, 12 of the 16 with metastases, eight of
the 18 with hemangiomas, all four with FNH, and three of
the seven with nontumorous lesions. All patients gave their
full informed consent to our study and the approval of our
institutional review board was obtained.
Hemangiomas were proven by means of characteristic
findings at triple-phase (hepatic arterial, portal venous, and
equilibrium phase) contrast-enhanced helical CT (n=11) or
dynamic contrast-enhanced MR imaging (n=10), with no
growth at follow-up imaging for a minimum of six months,
or by intraoperative biopsy (n=1). One focal fatty lesion
was verified by MR imaging using the fat suppression tech-
nique, and all other lesions were proven by percutaneous
needle biopsy (n=74) or resection (n=9). Pathologic proof
was obtained for each nodule, except in four patients with
metastases which were included in one scan plane. All
metastatic lesions in these four patients showed the same
enhancement pattern and were thus considered to be
pathologically similar to the one which was proven. The
histologic diagnoses of metastases were gastric carcinoma
(n=7), colorectal carcinoma (n=6), pancreatic carcinoma
(n=3), adenocarcinoma of unknown primary origin (n=3),
gallbladder carcinoma (n=1), malignant stromal tumor of
the duodenum (n=1), and non-small cell lung carcinoma
(n=1).
CHA Imaging
The US contrast agent used in the present study, SH U
508 A (Levovist; Schering AG, Berlin, Germany), is a sus-
pension of galactose microparticles in sterile water. In
preparation for its injection, and prior to US, this agent
was shaken for 5 10 seconds with 11 mL of sterile water.
After standing for 2 minutes for equilibration, a 4-gm
milky suspension of SH U 508 A at a concentration of 300
mg/mL was injected into the brachial vein as a bolus, using
a 20-gauge peripheral intravenous cannula.
Prior to final diagnosis, CHA US was prospectively per-
formed by either of two examiners (H.K.L. and H-J.J.). For
all US examinations, a 2-4-MHz curved-array wide-band
transducer (LOGIQ 700 MR EXPERT or LogiQ 9; General
Electric Medical Systems, Milwaukee, Wis., U.S.A.) was
used. The acoustic power of CHA US was set at the default
setting - an MI of 0.6 0.8. Before injection of the contrast
agent, the area including the tumor was focused by zoom-
ing, and with a single focal zone either at the bottom or at
the center of the lesions, depending on the size of the le-
sions. After administration of the contrast agent, CHA US
involving ‘modified interval-delay scanning’ was per-
formed, with a combination of continuous scanning and in-
terval-delay techniques, and the two different patterns of
images observed were differentiated during the two scan-
ning modes. The real-time assessment of intratumoral vas-
cular flow during continuous scanning at each interval was
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quential enhancement pattern seen during the initial one or
two frames of each interval scan was termed ‘acoustic
emission imaging’. During the first 60-second period after
injection, before reaching the point of maximal parenchy-
mal enhancement, lesions were scanned every 20 seconds
for 5 to 10 seconds, and between each scan the display was
frozen. Just after the end of each scanning period, a series
of hard-copy images was obtained as images were re-
viewed in cine-mode. During this phase (vascular imaging),
the intralesional vascular pattern was the main focus of
evaluation, though the SAE effect was frequently apparent
during the first few frames of each scanning period.
Modified intermittent scanning was then performed,
sweeping for 2 3 seconds with a 1- or 2-minute interval
(at 1-, 2-, 3-, and 5- minute delay); between each scan the
display was frozen, and for 2 3 seconds during each scan
was unfrozen. During this phase, the chief concern was the
sequential enhancement pattern, which relies mainly on
the SAE effect (acoustic emission imaging phase). The time
delay from injection and the time at which each image was
obtained were automatically recorded by a timer function.
Analysis
US images were retrospectively reviewed on a 2K 2K
picture archiving and communication system monitor
(General Electric Medical Systems Integrated Imaging
Solutions, Mt. Prospect, Ill., U.S.A.) by two abdominal ra-
diologists (W.J.L., S.H.K.) experienced in contrast-en-
hanced US and blinded to the final diagnosis.
The study coordinator (H-J.J.) annotated vascular phase
and acoustic emission images in advance on the sets of im-
ages. For vascular images, each reviewer was asked, in
each case, to categorize the vascular pattern as one of the
following five: irregular branching, randomly stippled, pe-
ripherally stippled, spoke-wheel, or no vascular signal (Fig.
1). As for acoustic emission images, the reviewers were
asked to categorize the pattern seen during the early phase
(start - 1 or 2 minute delay) as one of the following four:
peripheral nodular, peripheral rim or flame, heteroge-
neous, or homogeneous (hyper-, iso-, or hypoechoic to sur-
rounding parenchymal echogenicity). The evolving pattern
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Fig. 1. The intratumoral vascular patterns
seen during vascular phase imaging.
Table 1. Intratumoral Vascular Patterns Observed at Vascular Imaging
HCC Metastasis Hemangioma FNH Nontumor
Irregular branching 35/51 (69%)
Random stippling 14/51 (27%) 2/22 (9%) 1/22 (5%) 1/4 (25%)
Peripheral stippling 20/22 (91%)
Spoke-wheel 2/51 (4%) 3/4 (75%)
No vessel signal 21/22 (95%) 6/6 (100%)
Note. HCC = hepatocellular carcinoma, FNH = focal nodular hyperplasiawas then classified as centripetal fill-in, washout (becoming
hypo- or isoechoic to surrounding parenchymal echogenici-
ty), or persistent. Discrepancies in the findings were re-
solved by consensus. The reviewers were not asked to di-
agnose the lesions studied. All observations of the en-
hancement patterns were totally subjective and not sub-
stantiated quantitatively.
RESULTS
The intralesional vascular pattern seen at vascular imag-
ing (Table 1) and the enhancement patterns at acoustic
emission imaging (Table 2) are summarized in the tables.
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Fig. 2. Two characteristic vascular pat-
terns of HCC (arrows).
A. Irregular branching pattern.
B. Randomly stippled pattern.
AB
Table 2. Serial Enhancement Patterns at Emission Imaging
HCC Mets Hemangioma FNH
Early phase Peripheral nodular 19/22 (86%)
Rim/Flame 19/22 (86%)0
Heterogeneous 36/51 (71%)0
Homogeneous 15/51 (29%)00 3/22 (14%) 4/4 (100%)
Evolving pattern Washout (hypoechoic) 51/51 (100%) 22/22 (100%)
Washout (isoechoic) 3/4 (75%)0
Centripetal fill-in 19/22 (86%)
Persistently high 03/22 (14%) 1/4 (25%)0
Note. HCC=hepatocellular carcinoma, Mets=metastasis, FNH=focal nodular hyperplasia
The patterns observed at acoustic emission imaging of nontumorous lesions were difficult to classify.
Fig. 3. HCC (arrows). Serial acoustic emission images obtained at 20-sec (A), 2-min (B), and 5-min (C) delay show early enhancement
(A) and heterogeneous washout (B, C).
ABCHepatocellular Carcinomas
Tumor diameters as measured at US were 14 55 (mean,
25) mm. For HCCs, the most common intratumoral vascu-
lar pattern seen during the vascular imaging phase was ir-
regular branching vessels (69%, 35/51), followed by ran-
domly stippled vascularity (27%, 14/51) (Fig. 2). The intra-
tumoral vessels of the remaining two HCCs (4%, 2/51)
were judged to have a spoke-wheel appearance. During
the acoustic emission imaging phase, 71% of HCCs (36/51)
showed heterogeneous enhancement during the early
phase, and the echogenicity of all HCCs diminished and
became converse when compared with that of the
parenchyma. This was, in other words, a washout pattern
(Fig. 3).
Metastases
Tumor diameters as measured at US were 7 72 (mean,
23.5) mm. During the vascular imaging phase, 20 of 22
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Fig. 4. Metastasis from duodenal carci-
noma. Serial acoustic emission image
depicts rim-or flame-like enhancement
during the early phase (A, 40-sec delay)
and a homogeneous perfusion defect
during a later phase (B, 5-min delay).
AB
Fig. 5. Hemangioma. Serial CHA
acoustic emission images obtained dur-
ing the precontrast phase (A), and at 20-
sec (B), 1-min (C), and 5-min (D) delay,
clearly demonstrate typical peripheral
nodular enhancement with progressive
centripetal fill-in.
AB
CDmetastases (91%) showed a peripherally stippled pattern,
while the remaining two demonstrated randomly stippled
vascularity (2/22, 9%). During the early emission imaging
phase (1 2 minute delay), 86% (19/22) showed rim- or
flame-like peripheral enhancement (Fig. 4A) and the re-
maining three (3/22, 14%) showed homogeneous hypoe-
chogenicity, with no intratumoral enhancement. A periph-
erally stippled vascular pattern was also observed for the
few seconds remaining after emission imaging during this
phase. The echo intensity of the enhancing areas of the tu-
mor diminished (washout pattern), and the remaining areas
with no early-phase enhancement were persistently hypoe-
choic (Fig. 4B). Accordingly, scans obtained after a delay
of three or more minutes showed that all metastases be-
came homogeneous cold lesions within the enhancing
parenchyma.
Jang et al.
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Fig. 7. FNH (arrows). CHA images clear-
ly depict the typical spoke-wheel pattern
seen during the early vascular phase (A,
40-sec delay). The mass becomes isoe-
choic at late acoustic emission imaging
(B, 3-min delay), a tendency which may
help differentiate FNH from some HCCs
showing a similar spoke-wheel vascular
pattern but a washout pattern at late
acoustic emission imaging.
AB
Fig. 6. Unusual hemangioma with arteri-
oportal shunt (A, precontrast; B, 20-sec
delay; C, 42-sec delay; and D, 5-min de-
lay). Only 20 sec after injection (B), CHA
vascular phase imaging shows an early
draining portal vein (arrows) and intratu-
moral vascular stippling. However, per-
sistent homogeneous enhancement until
5-minute delay (D) led to the correct di-
agnosis.
AB
CDHemangiomas
Tumor diameters as measured at US were 7 52 (mean,
23) mm. During the acoustic emission phase imaging, 19 of
22 hemangiomas (86%) showed typical peripheral nodular
enhancement and progressive centripetal fill-in (Fig. 5),
and the remaining three (3/22, 14%) showed persistent ho-
mogeneous enhancement, also one of the characteristic en-
hancement patterns of hemangiomas. Although the intensi-
ty of enhancing areas of the tumor diminished progressive-
ly after injection, areas of enhancement enlarged and per-
sisted until the late phase of acoustic emission imaging. As
for vascular phase imaging, no intratumoral flow signal
was observed in 21 of 22 hemangiomas (95%) during the
continuous vascular-phase scanning. Only one unusual he-
mangioma, with arterioportal shunt, showed diffuse intra-
tumoral stippling during this phase scanning (Fig. 6).
Focal Nodular Hyperplasia
Tumor diameters as determined at US were 14 46
(mean, 28.5) mm. At vascular imaging, CHA clearly de-
picted the central arteries of the typical spoke-wheel pat-
tern in three of four cases (3/4, 75%) (Fig. 7A). At acoustic
emission imaging, the lesions showed a varying degree of
homogeneous enhancement during the early phase and
tended (3/4 cases, 75%) to be isoechoic during the late
phase (Fig. 7B).
Nontumorous Lesions
At US, lesion diameters were found to be 12 35 (mean,
23.3) mm. No lesions in this group (three FENs, two in-
flammatory nodules, and one focal fatty lesion) showed an
intralesional vascular pattern at vascular phase imaging
(Figs. 8, 9). At emission imaging, the focal fatty lesion was
hyperechoic at precontrast scanning, but after contrast ad-
ministration, its echo intensity became identical to that of
surrounding parenchyma at any phase of acoustic emission
imaging (Fig. 8). FENs showed a complete perfusion defect
in their center and fuzzy enhancement at the periphery,
but for the first one or two minutes, this was weaker than
that of surrounding parenchyma. Inflammatory nodules
showed a complete lack of enhancement at emission imag-
ing (Fig. 9).
DISCUSSION
CHA is a new contrast-specific gray-scale harmonic US
technique based on digitally encoded US technology. To
overcome the shortcomings of conventional harmonic
imaging, various gray-scale harmonic imaging techniques
have recently been developed (5, 7, 8, 11 13). Among
these, digitally encoded harmonic US is the one that en-
codes the unwanted fundamental frequency component
when transmitting pulses and then, through a decoding
process when receiving signals, removes the pre-tagged
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Fig. 8. Focal fatty lesion in a breast can-
cer patient. Portal venous phase CT (A)
shows a target-like hepatic nodule (ar-
row). At CHA vascular phase imaging (B,
40-sec delay), no vascular pattern is ob-
served (arrows), and during both other
phases of acoustic emission imaging (C,
3-min delay; D, 5-min delay), the lesion is
completely obscured; its enhancement is
the same as that of surrounding
parenchyma. Subsequent MR imaging
using the fat suppression technique (not
shown) confirmed the diagnosis of focal
fat deposition. AB
CDfundamental echo without the loss of overlapping harmon-
ic signals (14). The B-flow technique, optimized for direct
visualization of blood cells at gray-scale imaging, uses
codes to enhance weak blood echoes and equalize a non-
moving tissue signal (15), and is thus free of Doppler arti-
fact. Combining the advantages of the two techniques,
CHA employs a technique that separates harmonic signals
from tissue and those from contrast agents, and boosts har-
monic return from the latter while suppressing not only
fundamental but also harmonic signals from background
tissue (14). Thus, CHA is specifically sensitive to signals
from a contrast-agent, but without contrast-related arti-
facts. The resultant high sensitivity to a contrast agent pro-
vides sufficient SAE effect at medium MI, while other
gray-scale harmonic US techniques usually require maxi-
mal MI to achieve this (5, 6, 8). Furthermore, since there is
less destruction of microbubbles, a period of continuous
scanning is possible. CHA’s excellent sensitivity to contrast
agents also permits direct visualization of mobile mi-
crobubbles per se, present in intratumoral microvascula-
ture.
Previous studies in which contrast-enhanced harmonic
US was used to depict hepatic lesions (5, 6, 8, 16) have
mostly emphasized either the depiction of intratumoral
vasculature by continuous scanning or the importance of a
strict intermittent scanning technique to exploit the maxi-
mal SAE effect, according to the characteristics of the con-
trast agents and harmonic techniques used. Thus, in few
studies have both vascular and acoustic emission imaging
provided useful and detailed information. SH U 508A is
currently the most widely available US contrast agent, and
is known to be well tolerated in intravenous injection and
to have a good safety profile (7, 16). It is, though, an air-
based contrast agent which gives rise to weak harmonic
signals at low MI and is therefore less suitable for continu-
ous scanning (6). In a recent study (6) in which with SH U
508 A was used during vascular, interval-flash, and post-
vascular imaging at different MIs, vascular imaging at low
MI provided inconsistent data. On the other hand, con-
trast-agents containing higher density gas such as perfluo-
rocarbon are more durable, providing acceptable harmonic
imaging at low MI under continuous insonation (5). In our
experience, CHA using SH U 508 A gave rise to harmonic
signals which at low MI (0.2) were mostly inadequate for
acceptable imaging, in accordance with previous results. In
this study using SH U 508 A, we performed ‘modified in-
termittent scanning’, a combination of interval-delay and a
short period of continuous scanning, both at medium MI.
Before peak hepatic parenchymal enhancement was
achieved, the 5 10-second period of continuous scanning
was sufficient to observe the flow within intratumoral mi-
crovasculature, which was similar to that observed at con-
ventional angiography, and we obtained an initial frame of
acoustic emission images at the end of continuous vascular
Jang et al.
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Fig. 9. Inflammatory nodule in a rectal
cancer patient. Portal venous phase CT
(A) shows a hypoattenuating mass (ar-
row). CHA vascular phase imaging (B,
40-sec delay) reveals no vascular pattern
within the mass (arrows), which appears
as a perfusion defect at both other phas-
es of acoustic emission imaging (C, 2-
min delay; D, 5-min delay). Biopsy re-
vealed chronic inflammation and necro-
sis.
AB
CDimaging. After the portal venous phase, our main concern
was to observe the sequential dynamic enhancement pat-
terns acquired at acoustic emission imaging, as well as
those acquired at dynamic CT or MR imaging. The scans
obtained during the late phase usually gave little additional
information about vascular patterns.
The ability of both vascular and acoustic emission imag-
ing to provide excellent depiction of vascular and enhance-
ment patterns is noteworthy: combined information from
both phases was very helpful for accurate characterization.
In differentiating between HCC, metastasis and FNH,
recognition of the characteristic vascular pattern of each
tumor, as seen at vascular imaging, is very important; since
most malignant tumors exhibit a washout pattern and cold
defects at late acoustic emission imaging, the information
obtained from such imaging alone may not be sufficient to
differentiate HCC with central necrosis from metastasis. In
addition, our results showed that the vascular patterns of
HCC, metastasis and FNH could be potentially useful in
differentiating these from inflammatory nodules; at late
acoustic emission imaging, these latter sometimes appeared
as a cold lesion, similar to a malignant tumor, but showed
no vascular signal at vascular imaging. In many cases, the
evolving pattern seen at acoustic emission imaging also
provided helpful additional information. FNH tended to be
isoechoic or hyperechoic at late acoustic emission imaging,
and since all HCCs showed washout at acoustic emission
imaging, this finding may help differentiate between un-
usual HCC with a spoke-wheel vascular pattern and FNH.
The SAE effect frequently led to tumor enhancement even
as early as 20 seconds after administration of a contrast
agent, especially in hypervascular tumors. This early-phase
acoustic emission imaging thereby provides images similar
to those obtained at dynamic CT or MRI during the hepatic
arterial phase.
All hemangiomas showed one of two characteristic pat-
terns, which corresponded to the findings of dynamic CT
or MRI: peripheral nodular enhancement with progressive
centripetal fill-in (86%), or persistent homogeneous en-
hancement (14%). These findings were seen only during
one or two initial frames of each interval scan, suggesting
that these relied mostly on the SAE effect. In the next few
minutes, hemangiomas - except for one unusual one with
an arteriportal shunt - were completely unenhanced due to
bubble destruction caused by extremely slow circulation.
The detection of nodular or strong homogeneous enhance-
ment during an initial frame of each interval delay is there-
fore very important. Once typical nodular enhancement
was detected, we minimized the duration of continuous
scanning in order to exploit efficient acoustic emission
imaging during the late phase. Lengthening the interval de-
lay rendered this enhancement toward the center of the le-
sion (8) and vascular imaging provided little additional in-
formation for the diagnosis of hemangioma. As suggested
in our study and those of previous researchers (7, 8, 17),
hemangiomas may be confidently diagnosed solely on the
basis of contrast-enhanced gray-scale harmonic US find-
ings, without further invasive or costly studies.
Another potential benefit of our CHA technique is that
since there is time to adjust the scan field, it can be fairly
easily applied to a small lesion. Kim et al. (8) previously re-
ported the usefulness of pulse-inversion harmonic US in
characterizing focal hepatic lesions, but they dealt with
nodules at least 17 mm in diameter and their strictly inter-
mittent scanning procedure is difficult to apply to smaller
nodules. It is noteworthy that our cases included many
nodules about 1 cm or even less in diameter, and our pro-
cedure was especially useful for characterizing nonspecific
small hypoattenuating hepatic lesions detected at single-
phase helical CT in oncologic patients. Most small heman-
giomas or nontumorous lesions in our study were detected
incidentally in patients with malignancy. Moreover, unlike
Doppler techniques (1 4), even lesions located in the
dome of the left hepatic lobe were clearly demonstrated
without flash artifacts related to respiration, cardiac pulsa-
tion, or blooming, since CHA is free of Doppler or con-
trast-related artifacts. For the characterization of indeter-
minate focal hepatic lesions, CHA therefore appears to be
a promising problem-solving tool, especially where CT or
MR imaging has been inconclusive.
In spite of the many strong points described above, CHA
has several drawbacks. Firstly, its inherent limitation is that
the image quality of precontrast CHA is inferior to that of
conventional gray-scale imaging: CHA suppresses station-
ary background tissue signals, both fundamental and har-
monic, and is therefore unsuitable for routine hepatic ex-
amination and should be reserved for complementary
study involving contrast enhancement. Secondly, it is high-
ly dependent on the focal zone involved, and zooming in
and accurate focusing on the region of interest of the lesion
are thus important. Thirdly, harmonic signals from a deep-
seated lesion are often insufficient for acceptable imaging,
a general drawback of other harmonic techniques. Lastly,
the additional time required for encoding and decoding re-
sults in a small drop in frame rates.
The usefulness of our findings is limited by the following
problems. First, since baseline images may have included
diagnostic clues such as underlying cirrhosis or the typical
findings of a certain disease, the reviewers were not totally
blinded to the diagnostic findings. Second, except for one
malignant stromal tumor of the duodenum, no hypervascu-
lar metastasis was included in this study. In addition, in
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scanning technique either was not or could not be em-
ployed, and this should be born in mind when interpreting
our detection rate of almost 100% vis-a -vis vascularity in
HCC, metastasis, and FNH.
In summary, owing to its excellent sensitivity to the con-
trast agent used, contrast-enhanced gray-scale US using a
CHA technique permitted a period of continuous scanning
for the depiction of intratumoral vasculature, as well as in-
termittent acoustic emission imaging, and thus provided
characteristic findings of various focal hepatic lesions. To
verify the potential clinical utility our study suggests, fur-
ther investigation is warranted.
References
1. Goldberg BB, Merton DA, Forsberg F, Liu J-B, Rawool N.
Color amplitude imaging: preliminary results using vascular
sonographic contrast agents. J Ultrasound Med 1996;15:127-
134
2. Kim TK, Han JK, Kim AY, Park SJ, Choi BI. Signal from hepat-
ic hemangiomas on power Doppler US: real or artefactual?
Ultrasound Med Biol 1999;25:1055-1061
3.Choi BI, Kim TK, Han JK, Kim AY, Seong CK, Park SJ.
Vascularity of hepatocellular carcinoma: assessment with con-
trast-enhanced second-harmonic versus conventional power
Doppler US. Radiology 2000;214:381-386
4. Kim TK, Han JK, Kim AY, Choi BI. Limitations of characteriza-
tion of hepatic hemangiomas using an ultrasound contrast agent
(Levovist) and power Doppler ultrasound. J Ultrasound Med
1999;18:737-743
5. Wilson SR, Burns PN, Muradali D, Wilson JA, Lai X. Harmonic
hepatic US with microbubble contrast agent: initial experience
showing improved characterization of hemangioma, hepatocel-
lular carcinoma, and metastasis. Radiology 2000;215:153-161
6. Dill-Macky MJ, Burns PN, Khalili K, Wilson SR. Focal hepatic
masses: enhancement patterns with SH U 508A and pulse-inver-
sion US. Radiology 2002;222:95-102
7.Tanaka S, Ioka T, Oshikawa O, Hamada Y, Yoshioka F.
Dynamic sonography of hepatic tumors. AJR Am J Roentgenol
2001;177:799-805
8. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moo SG. Hepatic
tumors: contrast agent-enhancement patterns with pulse-inver-
sion harmonic US. Radiology 2000;216:411-417
9. Burns PN, Wilson SR, Simpson DH, Chin CT, Lai X. Harmonic
interval delay imaging: a new ultrasound contrast method for
imaging the blood pool volume in the liver. Radiology 1998;
209(P):189
10.Burns PN, Wilson SR, Muradali D, Powers JE, Fritzsch TT.
Intermittent US harmonic contrast-enhanced imaging and
Doppler improve sensitivity and longevity of vessel detection.
Radiology 1996;201(P):159
11.Ding H, Kudo M, Onda H, et al. Evaluation of posttreatment re-
sponse of hepatocellular carcinoma with contrast-enhanced cod-
ed phase-inversion harmonic US: comparison with dynamic CT.
Radiology 2001;221:721-730
12.Jang HJ, Lim HK, Lee WJ, Kim SH, Kim KA, Kim EY.
Ultrasonographic evaluation of focal hepatic lesions: comparison
of pulse inversion harmonic, tissue harmonic, and conventional
imaging techniques. J Ultrasound Med 2000;19:293-299
13.Albrecht T, Hoffman CW, Schettler S, et al. B-mode enhance-
ment at phase-inversion US with air-based microbubble contrast
agent: initial experience in humans. Radiology 2000;216:273-
278
14.Kim JH, Kim TK, Kim BS, et al. Depiction of typical enhance-
ment pattern of hepatic hemangiomas: coded harmonic angio
US with microbubble contrast agent. J Ultrasound Med 2002;
21:141-148
15.Furuse J, Maru Y, Mera K, et al. Visualization of blood flow in
hepatic vessels and hepatocellular carcinoma using B-flow
sonography. J Clin Ultrasound 2001;29:1-6
16.Ding H, Kudo M, Onda H, Suetomi Y, Minami Y, Maekawa K.
Hepatocellular carcinoma: depiction of tumor parenchymal flow
with intermittent harmonic power Doppler US during the early
arterial phase in dual-display mode. Radiology 2001;220:349-
356
17.Lee JY, Choi BI, Han JK, Kim AY, Shin SH, Moon SG.
Improved sonographic imaging of hepatic hemangioma with
contrast-enhanced coded harmonic angiography: comparison
with MR imaging. Ultrasound Med Biol 2002;28:287-295
Jang et al.
100 Korean J Radiol 4(2), June 2003